AB Science (ABSCF.PK) announced that the European Medicines Agency (EMA) has approved an extension of the shelf life of its veterinary medicine, MASIVET, to 48 months from 36 months. This applies specifically to the 50mg tablet version available in the European Union.
MASIVET is used to treat non-resectable mast cell tumors in dogs (Grade 2 or 3) with confirmed mutations in the c-kit tyrosine kinase receptor. The shelf-life extension allows greater flexibility in inventory management, helping patients, caregivers, and veterinarians maintain treatment availability while reducing the risk of product expiration. This change supports continued access to effective therapies across all EU countries.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.